Critical Review: Envoy Medical (NASDAQ:COCH) versus Demant A/S (OTCMKTS:WILYY)

Envoy Medical (NASDAQ:COCH) and Demant A/S (OTCMKTS:WILYY) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Envoy Medical and Demant A/S, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	3	0	3.00
Demant A/S	0	0	2	0	3.00

Envoy Medical presently has a consensus price target of $7.25, suggesting a potential upside of 234.10%. Given Envoy Medical’s higher possible upside, research analysts plainly believe Envoy Medical is more favorable than Demant A/S.

Volatility and Risk

Envoy Medical has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Comparatively, Demant A/S has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500.

Earnings and Valuation

This table compares Envoy Medical and Demant A/S’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$297,000.00	143.21	-$29.91 million	N/A	N/A
Demant A/S	$3.26 billion	2.39	$260.63 million	N/A	N/A

Demant A/S has higher revenue and earnings than Envoy Medical.

Profitability

This table compares Envoy Medical and Demant A/S’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	N/A	N/A	-112.11%
Demant A/S	N/A	N/A	N/A

Summary

Envoy Medical beats Demant A/S on 6 of the 9 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Demant A/S

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.